Nomad Foods Ltd
NYSE:NOMD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.85
19.93
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nomad Foods Ltd
You don't have any saved screeners yet
Ladies and gentlemen, greetings, and welcome to the Nomad Foods Fourth Quarter and Full Year 2022 Earnings Call. A brief question-and-answer session will follow the formal presentation [Operator Instructions]. As a reminder, this conference is being recorded.
It is now my pleasure to introduce you to your host, Anthony Bucalo, Investor Relations. Please go ahead.
Hello, and welcome to the Nomad Foods Fourth Quarter 2022 Earnings Call. I'm Anthony Bucalo, Head of Investor Relations, and I am joined on the call by Stefan Descheemaeker, our CEO; and Samy Zekhout, our CFO. Before we begin, I would like to draw your attention to the disclaimer on Slide two of our presentation. This conference call may include forward-looking statements that are based on our view of the company's prospects, expectations, and intentions at this time. Actual results may differ due to risks and uncertainties, which are discussed in our press release, our filings with the SEC, and this slide in our investor presentation, which includes cautionary language. We will also discuss non-IFRS financial measures during the call today. These non-IFRS financial measures should not be considered a replacement for and should be read together with IFRS results. Users can find the IFRS to non-IFRS reconciliations within our earnings release and in the appendices at the end of the slide presentation available on our website. Please note that certain financial information within this presentation represent adjusted figures for 2021 and 2022. All adjusted figures have been adjusted for exceptional items, acquisition-related, share-based payment, and related expenses as well as non-cash FX gains or losses. Unless otherwise noted, comments from here on will refer to those adjusted numbers. With that, I will hand you over to Stefan.
Thank you, Tony, and thank you for joining us on the call today. I am pleased to report that 2022 marked our sixth consecutive year of generating record sales, adjusted EBITDA, and adjusted EPS. I would like to thank all the dedicated people at Nomad who made it possible under historically challenging conditions. Last year, we made significant adjustments to our business model as we evolve to mitigate the impact of COVID-19 and the Ukraine war. Importantly, we maintain our strong foundation speed on world-class people, equating brands in a great category and healthy financials that will allow us to continue investing for the long term. Frozen food remains a great value for consumers with sustainable growth expected ahead. Frozen food is high in nutrition, low in waste and the best value for money across the food category. During periods when consumers are looking for value in nutrition in their food choices, frozen food needs them and more. As the category leader, Nomad is positioned to deliver that value to our millions of consumers. In 2020 and '21, our business excelled during the COVID lockdown as consumers' pantry loaded and had more frozen means at home, adopting many of our products into their everyday lives. I'm happy to say that we have held on to most of these games.
In 2022, we started the year with the supply chain still under pressure from the COVID impact. The war in Ukraine further complicated the situation, creating historic input cost increases and consumer uncertainty. We took four major steps to successfully mitigate the short and long-term disruptions. First, we derisked our fish supply by diversifying our species and geographies while ramping up high-quality farm sources. Second, we leveraged our powerful supply chain to build inventories of key ingredients to protect against any shortages. Third, we successfully priced our products to close the gap with this reinflation. Finally, we refinanced our debt portfolio in November, extending our debt maturities to mid-2028 and 2029. We believe that 2023 is setting up to the transitional year to a more normalized consumer environment. With the improvements we implemented in our business last year, the plans we have in place for this year, we are on the right path to meet our financial objectives and maintain our growth. We also have the right plans in place to capture market share, boosted by our great brands communication and innovation. We plan to strengthen our brand by increasing investment in A&P, and this is especially crucial as conditions normalize. We will also be broadening our affordable choices to address inflationary pressures on consumers. We will manage our supply chain for greater efficiency and use those cost savings to enhance lines of plant growth.
Finally, we plan to maximize the value of our portfolio through prudent pricing and improved revenue growth management strategy. This will help drive our efforts to recruit the COVID-19 impact of two years of recutting cost inflation. Revenue growth management will be especially important as we maximize the value of our portfolio and win market share by placing the right product at the right place and at the right price. Taken together with the expected rebounding of our cash flow and the increased visibility of extended debt maturities, we believe we have significant flexibility to return cash to shareholders while positioning our business for growth beyond next year. We will be taking a deeper dive into our strategy later today at CAGNY, and we hope you will join us again. With that, I'd like to recap our 2022 key financial metrics, beginning with reviews. Q4 organic revenues grew 7.7% or a third sequential quarter of improving sales trends. Our full-year organic revenues grew 1.8% as of price increases in the back half of the year offset volume declines. This low single-digit organic sales performance is in line with our guided expectations from the beginning of the year. Adjusted gross margin declined 80 basis points to 25.7% in the fourth quarter and declined 120 basis points for BDA. We saw a sequential improvement in gross margin trends in the second half due to our pricing initiatives. Adjusted EBITDA was up slightly at €130 million in Q4 and grew 8% to €524 million for the year. And finally, adjusted EPS was €0.33 per share in Q4, flat versus last year. At current US dollar cost rate, our Q4 adjusted EPS was $0.35.
Adjusted EPS was impacted by our non-vetere financing, and we saw an approximately €0.02 impact on earnings for Q4 and for the full year. Despite a historically challenging macroeconomic environment, we delivered another record financial performance in sales, adjusted EBITDA, and adjusted EPS. Since 2016, we have increased our total reviews by more than 50%, adjusted EBITDA by more than 60%, and doubled our adjusted EPS. We have generated more than €1.7 billion in adjusted free cash flow during that period as well. Our organic revenues returned to growth as successful price increases exceeded mid-single-digit declines in full-year volume and mix. In the fourth quarter, we further narrow the gap between price and input costs, a gap, which has widened after the outbreak of the war. When looking ahead to this year, our diode remains active with retailers regarding further base to our pricing. Adjusting pricing will allow us to recover costs while protecting the business with step-up investments in A&P and innovation. Excellence in execution is a hallmark of Nomad and our supply chain has a great performance. Our service levels ended the year up 96.6%, a 30 basis point improvement. As of today, we have more than 50% of raw material cost covered for the coming year. We believe our supply chain is a source of competitive strength in the source of savings to sustainably help fund top-line growth this year and beyond. Last year, we raised prices to protect our margins and ensure that we have the appropriate profitability to invest in our business. Many of our private-label competitors did not follow our pricing. As a result, we've seen volume declines and margin losses in market share. However, this was predicted in this part of a broader process.
We believe volume and market share losses are short-term in nature, which we expect to rebound this year as we will discuss at CAGNY later today. We successfully extended our debt maturity profile in November. We refinanced our $960 million Term Loan B due mid-2024 with 2 terms totaling to $830 million due in 2029. Our debt portfolio is now secured until mid-2028 and €29 at the competitive interest cost and is 75% fixed. With our maturities extended, we now have significantly more attitude in executing our use of cash strategies. This year, we're taking important steps to make Nomad strong in the market and better positioned for long-term growth. First, we refinanced our debt in November to give us greater visibility on the how to invest our cash. Commercially, we're investing in our brands with great A&P to ensure that we have the resources to innovate and grow our leadership position. When accounting for higher interest charges and stepped-up investments, we are establishing our 2023 adjusted EPS guidance at the range of €1.50 to €1.65 to reflect those investments. This represents an adjusted EPS range of $1.61 to $1.66, at current US dollar spot rates. The guidance excludes any impact of capital allocation. Excluding the impact of incremental interest in investment in A&P and people for 2023, our forecast adjusted EPS range for this year would have been in the range of €1.70 to €1.75. This would also have excluded any positive impact from capital allocation. We made significant adjustments to our business model as we navigated last year's volatile macroeconomic environment. First, we completed a major initiative to protect our fish supply. Throughout the year, we continually solve alternative sources for our signature fish products. We also secured new high-quality farm fish, and we expect to see the benefit of that early this year.
We believe this project, the security of high-quality supply for sourcing, but also provides opportunities to exercise pricing power budgeting fish in the future. Second, we leveraged our world-class supply chain to address volatile markets against unprecedented cost increases. Procurement was a key source of strength in 2022 as we build raw material inventories to protect against possible shortages. Our service levels improved for the full year, delivering consistently for our customers and consumers. We continue to improve our supply chain efficiencies through intense internal cost control programs, and we expect much of the savings to be reinvested in top-line growth this year. Finally, we priced to close the gap legislation in a difficult year, we priced one in the first quarter. However, with the outbreak of the war in Ukraine, we saw rapid increases in raw material prices and we were compelled to act. We took pricing throughout the year where appropriate and made significant progress, including the gap between price and costs. We will enter this year with the improving margins needed for investment in our brands. Alongside a vigorous revenue growth management strategy, we will continue to press consistently with the inflationary market dynamics as they occur. With that, I will now hand the call over to Samy to review our financial results and guidance in more detail. Samy?
Thank you, Stefan, and thank you all for your participation on the call today. Turning to Slide 7. I will provide more detail on our key fourth-quarter operating metrics, beginning with reported revenues, which increased 6.6% to €750 million, up 7.7% organically. Fourth quarter revenues were negatively impacted by 1.1% of unfavorable effects. For the year, total revenues were up 12.8%, driven by 1.8% organic growth and 10.8 percentage points from acquisitions. Overall, our sales benefited from lapping 2021 comparisons as well as strong pricing execution across all four quarters of the year. We did see elasticity in our top-line performance. This impacted our market share and overall volumes. Our volume and mix was up mid-single digits, while our value share was up about 0.5 point for the year. We expect market share to improve sequentially this year due to our innovation efforts on value and affordability as well as stepped-up A&P investments. Adjusted gross margins were 25.7% during the quarter, reflecting an 80 basis point decline versus the prior year. Margins were impacted by higher raw material costs, offset to some degree by pricing. This is the second quarter in improving gross margin trend. We will continue to look at pricing to stay price competitive in the market and manage any additional inflation. However, as we look out to the next year, our expectation is for a relatively stable gross margin as we will continue to recoup costs through price. Finally, we are planning to refresh our universal share statement on Form F-3 on March 1 to ensure that we can continue to access capital markets efficiently. No offerings are currently planned. Moving down to the rest of the P&L. Our adjusted gross profit grew 3% to €193 million for the fourth quarter. Adjusted COGS increased to €558 million, an increase of 7.7% and €40 million versus last year. Adjusted operating expense of €103 million was up 9% year-over-year.
Our adjusted EBITDA and our adjusted EPS performances were positively impacted by higher pricing in our core business, offsetting a considerable portion of our raw material cost for this quarter and the full year. Fourth quarter adjusted EBITDA of €113 million was up slightly versus last year. Adjusted EBITDA margin ended at 15.1%, a decline of 90 basis points. Finally, our adjusted EPS of €0.33 was flat in Q4. This translates to €0.35 in U.S. dollar terms at spot rate. Adjusted EPS was negatively impacted by debt refinancing, and this had a roughly €0.02 impact on earnings for Q4 and for the full year. Full-year adjusted gross profit grew 8% to €85 million. Full-year COGS increased to just above €2.1 billion, up 14%, driven by raw material inflation. Full-year adjusted operating expense grew 12% for the year to €380 million. As a percentage of sales, adjusted operating expense was flat at 13%. Full-year adjusted EBITDA ended at €524 million, up 8%. Adjusted EBITDA margin was 17.8%, also down 90 basis points from last year. Full-year adjusted EPS of €1.68 landed in the middle of the guidance range we provided in Q2 earnings of 8%. This was $1.80 at current US dollar spot rates. Excluding our November refinance, we estimate our 2022 adjusted EPS would have been €1.70 or $1.82 at current $spot rates. Turning to cash flow on Slide 9. We generated €189 million of adjusted free cash flow for a cash flow conversion of 65%. Cash flow was impacted by a working capital increase of €96 million and the one-time implementation of the unfair trade practice directive or PPD, in the EU and €80 million drag. In 2023, with more normalized working capital levels and new PPD in the base, we expect to return to a cash flow conversion of 90% to 95%.
Our cash flow performance was short of our typical annual goal of 90 to 95% conversion. However, we took important steps last year to protect our business by building raw material inventories to mitigate shortage risk. We made it a top priority to guarantee supply for our customers and consumers, and we did so. We are proud of this accomplishment, and we believe keeping products on the shelf was crucial in maintaining the confidence of our retail partners and consumers. Condition in the raw material markets are improving, and we have begun reducing working capital. We expect to continue to install throughout this year. CapEx of €79 million was flat versus last year. We supported strategic investments and integrated our recent acquisitions into our broader company spending plan throughout the year. Changes in cash tax decreased €50 million to €80 million, while cash interest was €22 million to €80 million, mostly due to the comparison with last year's refinancing period.
With that, let's turn to Slide 10 to review our 2023 guidance, which we are initiating today and is based on foreign exchange rates as of February 21, 2022. Starting with the top line, we expect revenue growth in the mid-single-digit range for the year. We expect our pricing initiatives to offset expected volume declines, declines at which we expect to rebound. We expect this year's cash flow to be consistent with our historical performance. With our working capital and new PPD adjustment behind us, we expect our cash conversion ratio to rebound the previous level, 90% to 95%. As Stefan highlighted in his opening comments, with higher interest costs from our refinancing and stepped-up commercial investments, we expect adjusted EPS in a range of €1.50 to €1.55 per share or $1.61 to $1.66 at current $spot rates. This excludes any impact of capital allocation. When excluding the impact of incremental interest and stepped-up investments in A&P and people for this year, our forecast adjusted EPS range from 2023 would have been €1.70 to €1.75. This also would have excluded any positive impact from capital allocation. I will now turn the session over to Q&A. Operator, back to you.
Thank you. Ladies and gentlemen, at this time, we will be conducting a question-and-answer session [Operator Instructions]. Our first question comes from the line of Andrew Lazar from Barclays.
Maybe to start off, fourth quarter gross margins came in below where we had forecast. Pricing was in line with what we modeled and volume was even a little bit better. So I was hoping, first, just to get perspective on what -- I know the margins sequentially improved, but they really were so down year-over-year. So I'm curious what drove some of that as a starting point.
Andrew, actually, that was exactly in line with what we had planned for, which was effectively the continuation of the execution of our pricing strategy to recover cost and costs are flowing through the quarter. So it's just a question of phasing and timing. I mean, on that one, that doesn't change the point and the strategy to recover inflation through pricing. Sorry, just an additional point. We are pricing ahead of the others anyway.
Then I know you talked about stable gross margins for the year, I think, in '23. I was hoping you could add a little context maybe around the expected sort of cadence. Would we expect gross margin to still be under some pressure in the first part of the year and then start to recover a bit in the back half to get stability for the year? Or just any perspective on cadence of margin and profitability through the year would be helpful.
It's exactly that. We won't see the significance of, let's say, the change that we saw last year, but effectively now if you in the full process of pricing is in place, we have now very good visibility on the inflation as we move forward. So effectively, we will see a sequencing of the gradual improvement of the margin over the year, absolutely.
Our next question comes from the line of John Baumgartner from Mizuho Securities.
Samy, just thinking of the cost environment for 2023, I don't think I heard you give an actual cost inflation estimate for this year, although I may have missed it. So just wanted to confirm on that front. And then I think I heard that more than 50% of your raw materials are covered for this year, which I think is sort of similar to where it was back in November. And it sounds like you have good visibility into cost at this point. So can you just sort of reconcile has anything changed structurally with the shift in fish sourcing where that precludes you from taking that coverage position higher at this point? Are you expecting relief and you're giving sell flexibility where you haven't taken coverage higher at this point? How do you think about the cost environment going forward right now?
Absolutely. I think we have mentioned the point that, let's say, after a year of significant inflation in 2022, we are seeing effectively the trend softening, okay? Clearly, it is not moving to a point of decline, but effectively, we're seeing much lower inflation on several of the raw material and packing material across the board the world. So the inflation level that we are going to face in 2023 will be lower than the one of 2022, but will still be there and will require some pricing action in order to continue on the journey of protecting our, let's say, cost structure in order for us to allow for investment in the future. The 50% that has been mentioned by John, was actually a projection we stated that by the end of the year, we intended to be in the range of about 50-plus percent, and we're continuing on that journey. Now, why aren't we increasing that is because there are down trends now in the market and we want to opportunistically take the, let's say, action in order for us to source ourselves at a lower cost when effectively the ingredient prices are going down. So effectively, we feel that staying at that level makes sense given the trend that we see in the market, I mean, at this stage. But of course, if there are opportunity to look good prices in relation to the type of inflation we're expecting effectively will do so for sure.
And then just quickly on Fortenova. I'm curious the expectations for 2020. I know you've been sort of ahead of pace with integration, rolling out additional coolers. Operationally, is there anything different we should be looking for in 2023 in terms of innovation, distribution, anything in the marketplace there? And is it fair to think that in 2023 for Fortenova, the revenue growth should be accretive to the guidance you've given for the overall company?
Well, the answer to your second question is yes, absolutely. And what we're also going to see in 2023 is, as you know, integration takes time. So the first year I mean we did very well, but the integration is a multiyear process, and '23, obviously, is going to accelerate this process. So we're very pleased with what we see in Fortenova. We also see that, for example, we have top-line synergies by combining with our products as well. We also see some opportunities that will be -- I will not mention too much at this stage -- time will come where we can see some reverse top-line synergies, more specifically in ice cream, where it makes sense. We're never going to change our point about must win battles where we need to be strong weight matters, but we see some interesting options in very carefully chosen places where ice cream may make sense. So very pleased. And quite frankly, as always, in the can situation, you see also things that you not necessarily have seen when you started. But overall, what I can see is definitely more good news than bad news.
Our next question comes from the line of Rob Dickerson from Jefferies.
I guess just a question around the brand investment. I think, Samy, I believe last quarter, you had said you would like the gross margin to kind of approach back into at least the high 20% level until you were able to lean into the business a little bit more aggressively. Now clearly, you are leaning in. It sounds like that's out of kind of near-term need. So I'm just curious, as you speak to kind of offering maybe more value-based products, right? It doesn't sound like there's this intention to really materially increase promotional spend, but maybe rather kind of be shifting the mix to some extent to recapture some of that volume share as we get through the year. So maybe if you could just provide a little bit more color as to kind of where the brand investment is going? And if there is some gradual kind of product offering shift to now more effectively compete against the lower price private label?
Actually, we will be considering both. And I think your question is probably about the balance. The reality, if you want, is that over the past 2 years, we have for right reason if you don't take down our investment in the A part of the E&P in advertising. And with the strength of our brands, in particular on awareness and equity strength overall, we feel this is the moment to recapture some of this and really emphasize the communication on our brands on what they are, what they stand for vis-a-vis the consumer, and as well to regain momentum with the retailers because they really view us as the category captain there. So we will be reinvesting back on the core of the brands on the innovation as well as on some of the cost of living innovation that we are driving in the market. So that's part of the A. On the B side, there will be an element that's going to be important. We are not going to tolerate volume share loss, and overall share loss, if you we will be taking action when it comes to, let's say, staying competitive versus our competitors, particularly private labels and discounters in order for us to maintain the price level that are needed. We expect them to overall get to the same reality as we are facing from an inflation standpoint and have to price for that. But at the same time, we will need as well to be promo competitive in order for us to maintain our competitiveness in store on that one. So it's going to be really a balance, I think, Rob, on that one, which is really needed above the line and below the line.
And then just quickly, for the guide, pricing more than offsetting volume declines but then also hoping that there's a recapture volume share so does that imply as, let's say, at least if we're sitting here in maybe Q4 of next year that hopefully here, the expectation is that volumes could actually turn positive? That's all I have.
Well, that's definitely the concept for us is simple. At this stage, with the price gap we have, we're losing volume, which was expected. To Samys' point, in the meantime, we're also starting to invest big time in A and B. I think just want to emphasize the GM program that we're putting in place, which is quite frankly, very strong. At the same time, while we see also some signals from some top competition that they're starting to increase price. And also to match Samys' point, inflation is starting to soften. So all these elements taken together, things we can control and things we control less obviously, makes us much more confident from that standpoint for the second part of the year.
And if I may, Rob, just to complement Stefan's point, I think, to your point, I think it's going to be something around between the quarter 4 and Q1 of the following year, but the intended effect is to see a smoothening down of the volume decline as the year-end and then gradually get back to normalization in 2024 and regaining momentum on the volume side at that time.
Well, traditionally, when you see any economic downturn, what we see in our category is two things for the time being. One is Frozen is doing very well for obvious reasons. It's affordable. It's convenient, it's good value for money. So that's obviously very good for all the players and starting with us. And also temporarily private labels are doing well for the reasons we mentioned. And that's why I think Samy is absolutely right to mention that it's going to be gradual, also helped by our investment program.
Our next question comes from the line of Cody Ross from UBS.
My first question, I just want to compare or if you can compare and contrast your volume today versus your volume pre-COVID. Are you seeing more volume come through the system or is volume down given all the pricing that you've taken over the last few years? And then I have a follow-up.
From a volume standpoint in aggregate, what we are seeing is about a slight decline versus the pre-COVID. Remember in COVID times, we had a substantial increase in our volume in the range of about, I think, high single-digit at that time. Then it started to erode the effect after the past year, we had about the same amount. So I would say from a pure volume standpoint, we are clearly slightly down. However, I think what's really important to note there is that from a consumer reach standpoint, actually, we are now reaching more consumers versus where we were pre-COVID, about 0.5 million more consumers. And that was really a very important point for us given the strength and the momentum we have got doing COVID is to maintain this consumer share, if you want, higher than what we had pre-COVID but volume are high.
And my follow-up is just around 2025. I didn't see anything in the press release or the slides today about your 2025 targets I just wanted to go back to there, how comfortable are you with your 2025 targets, just especially on EPS, given it would require over a 20% CAGR to hit that? And if you are comfortable, just what drives your confidence?
To make it simple, we are still on track operationally for 2025. At the same time, the interest rate environment has changed since we established that guidance, as you may remember. So looking ahead to 2025, we are strengthening our investment plans. You heard about it. It's going to be funded in '23 and beyond funded by cost savings to sustain our growth momentum in the years to come. And we're committed, as we always have been in the CEO record to deliver superior shareholder returns, and we have many options available for us to achieve this. You can remember the kind of capital allocation program we've been through these years, it's quite significant.
Our next question comes from the line of John Tanwanteng from CGS Securities.
This is Stefanos Christ calling in for John. Can you just talk about your plans for the improved cash flow this year? Is debt paydown the most attractive? Or are you seeing opportunities for repurchases or M&A?
This is very interesting, we're reviewing all options. I mean that we have a wide array of options, I mean ahead of us. I mean effectively ranging from share buyback to effective M&A and other elements relating to capital allocation. What's important to really highlight is the fact that we are returning to a strong cash flow performance in 2023. And we really now are going to consider all possibilities in order for us to maximize the return on the, let's say, to shareholders overall.
And just a little more detail on the price increases. Can you just talk about how receptive your customers have been compared to negotiations in the past few years?
Overall, remember, a year ago when we were, I think, let's say, at CAGNY and announcing effect that we had to go through a second pricing, there was an element of question mark. And frankly, the three price increase over the year have gone through reasonably well. And we haven't seen any dislocation whatsoever, given the dialogue that we have undertaken with the retailer and the way we've been executing the pricing overall by leveraging not only just lease price. But as Stefan was alluding to, all of the possibilities of our renewed RGM, revenue growth management strategy, I would say, on that one. So what has been going through in '22 has gone reasonably well with two markets that are kind of spilling over into 2023, which are going to execute the pricing, but clearly a bit later. We will have to clearly continue on this pricing journey because of the fact that there is still inflation in 2023, be it if you want smaller. But as I said, it's a question, frankly, of laying down the issues well and finding the right balance between top and bottom line and our growth versus affected the retail growth and while staying competitive with our customers. I mean with our consumers, I would say, overall. So far, as I said, it's been going quite well overall. And we are very happy when you think about the context into which this has been realized with an ongoing changing environment, I think the organization has gone absolutely brilliant job in order to execute, I mean, something that was deemed to be viewed, I mean, impossible and which is now in market as we speak.
As there are no further questions, sir. I would now like to turn the conference over to Stefan Descheemaeker, Chief Executive Officer, for any closing comments.
Thank you, operator, and thank you for your participation on today's call. 2022 was another eventful year with many challenges to address. We adjusted to Brexit, we adjusted to Brexit to COVID, and we have now adjusted to unprecedented inflation pressures. Frozen food remains the best value for consumers across food, and we remain focused and committed to delivering our ambitious financial objectives. And I look forward to speaking with you at CAGNY to give you more details on our plans. So thank you all, and back to you operator.
Thank you. The conference of Nomad Foods has now concluded. Thank you for your participation. You may now disconnect your lines.